DK0516349T3 - 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister - Google Patents
2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonisterInfo
- Publication number
- DK0516349T3 DK0516349T3 DK92304653.6T DK92304653T DK0516349T3 DK 0516349 T3 DK0516349 T3 DK 0516349T3 DK 92304653 T DK92304653 T DK 92304653T DK 0516349 T3 DK0516349 T3 DK 0516349T3
- Authority
- DK
- Denmark
- Prior art keywords
- beta
- hydroxy
- adrenoceptor agonists
- phenylethylamine derivatives
- phenylethylamine
- Prior art date
Links
- 102000012367 Beta 3 adrenoceptor Human genes 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 108040005346 beta3-adrenergic receptor activity proteins Proteins 0.000 title 1
- ULSIYEODSMZIPX-UHFFFAOYSA-N phenylethanolamine Chemical class NCC(O)C1=CC=CC=C1 ULSIYEODSMZIPX-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/04—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C251/06—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
- C07C251/08—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton being acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/22—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
- C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/04—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C251/10—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
- C07C251/16—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919111426A GB9111426D0 (en) | 1991-05-28 | 1991-05-28 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0516349T3 true DK0516349T3 (da) | 1995-11-06 |
Family
ID=10695679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92304653.6T DK0516349T3 (da) | 1991-05-28 | 1992-05-22 | 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister |
Country Status (32)
| Country | Link |
|---|---|
| US (3) | US5393779A (zh) |
| EP (1) | EP0516349B1 (zh) |
| JP (1) | JP3232337B2 (zh) |
| KR (1) | KR920021492A (zh) |
| CN (1) | CN1031564C (zh) |
| AP (1) | AP301A (zh) |
| AT (1) | ATE128115T1 (zh) |
| AU (1) | AU652826B2 (zh) |
| BG (1) | BG96392A (zh) |
| BR (1) | BR9202002A (zh) |
| CA (1) | CA2068377A1 (zh) |
| CS (1) | CS159292A3 (zh) |
| DE (1) | DE69204906T2 (zh) |
| DK (1) | DK0516349T3 (zh) |
| ES (1) | ES2076688T3 (zh) |
| FI (1) | FI922424A (zh) |
| GB (2) | GB9111426D0 (zh) |
| GR (1) | GR3017462T3 (zh) |
| HU (2) | HU211401B (zh) |
| IE (1) | IE69043B1 (zh) |
| IL (1) | IL101821A0 (zh) |
| MY (1) | MY136249A (zh) |
| NO (1) | NO922113L (zh) |
| NZ (1) | NZ242643A (zh) |
| OA (1) | OA10077A (zh) |
| PL (1) | PL294704A1 (zh) |
| RO (1) | RO111569B1 (zh) |
| RU (1) | RU2073666C1 (zh) |
| SI (1) | SI9200093A (zh) |
| TW (1) | TW198709B (zh) |
| YU (1) | YU54592A (zh) |
| ZA (1) | ZA923356B (zh) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO179246C (no) * | 1991-11-20 | 1996-09-04 | Sankyo Co | Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav |
| US6696486B1 (en) * | 1992-01-22 | 2004-02-24 | Glaxo Group Limited | Medical use for atypical β-adrenoceptor agonists |
| DE69331783T2 (de) * | 1992-01-22 | 2002-11-21 | Glaxo Group Ltd., Greenford | Medizinische Verwendung von atypischen Beta-adrenoceptor Agonisten |
| GB9207964D0 (en) * | 1992-04-10 | 1992-05-27 | Ici Plc | Chemical compounds |
| GB9209076D0 (en) * | 1992-04-27 | 1992-06-10 | Ici Plc | Chemical compounds |
| US5662934A (en) * | 1993-01-05 | 1997-09-02 | Najarian; Thomas | Compositions and methods for lowering cholesterol while maintaining antioxidant levels |
| GB9313574D0 (en) * | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Medicaments |
| US5482971A (en) * | 1993-10-01 | 1996-01-09 | American Cyanamid Company | Beta3 -adrenergic agents and their use in pharmaceutical compositions |
| US5563171A (en) * | 1993-11-05 | 1996-10-08 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists |
| US5578638A (en) * | 1993-11-05 | 1996-11-26 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists |
| US5541197A (en) * | 1994-04-26 | 1996-07-30 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| US5561142A (en) * | 1994-04-26 | 1996-10-01 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| US5627200A (en) * | 1994-09-26 | 1997-05-06 | Pfizer Inc | β3 -Adrenoceptor agonists and antagonists for the treatment of intestinal motility disorders, depression, prostate disease and dyslipidemia |
| US5847008A (en) * | 1996-02-02 | 1998-12-08 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
| US5859051A (en) * | 1996-02-02 | 1999-01-12 | Merck & Co., Inc. | Antidiabetic agents |
| US6090836A (en) * | 1996-02-02 | 2000-07-18 | Merck & Co., Inc. | Benzisoxazole-derived antidiabetic compounds |
| US6020382A (en) * | 1996-02-02 | 2000-02-01 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
| US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
| US6160000A (en) * | 1996-12-23 | 2000-12-12 | Merck & Co., Inc. | Antidiabetic agents based on aryl and heteroarylacetic acids |
| CA2329004C (en) * | 1998-06-30 | 2009-04-14 | Takeda Chemical Industries, Ltd. | Combination of insulin sensitizer with anorectic for treating or preventing diabetes |
| WO2001054728A1 (en) * | 2000-01-28 | 2001-08-02 | Asahi Kasei Kabushiki Kaisha | NOVEL REMEDIES WITH THE USE OF β3 AGONIST |
| US6987131B1 (en) | 2000-06-26 | 2006-01-17 | Burzynski Stanislaw R | Phenylacetic acid compositions for treating or preventing hypercholesterolemia |
| AU2001285311B2 (en) | 2000-08-29 | 2005-09-15 | Biocon, Ltd | Immunoregulatory compounds, derivatives thereof and their use |
| GB0102407D0 (en) | 2001-01-31 | 2001-03-14 | Glaxo Group Ltd | Process |
| US7709677B2 (en) | 2001-01-31 | 2010-05-04 | Glaxosmithkline Llc | Process of preparing arylethanoldiamines |
| JP2004331500A (ja) * | 2001-02-16 | 2004-11-25 | Dainippon Pharmaceut Co Ltd | 血中濃度制御製剤 |
| EP1236723A1 (en) | 2001-03-01 | 2002-09-04 | Pfizer Products Inc. | Sulfamide derivatives useful as beta3 agonists and pharmaceutical uses thereof |
| US8048924B2 (en) * | 2001-08-29 | 2011-11-01 | Biocon Limited | Methods and compositions employing 4-aminophenylacetic acid compounds |
| US6864268B2 (en) | 2002-02-27 | 2005-03-08 | Pfizer Inc. | β3 adrenergic receptor agonists |
| MXPA04008298A (es) | 2002-02-27 | 2004-11-26 | Pfizer Prod Inc | Procesos e intermedios utiles en la preparacion de agonistas de receptor beta-3 adrenergico. |
| AU2003209527A1 (en) * | 2002-02-27 | 2003-09-09 | Pfizer Products Inc. | Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol |
| ES2565848T3 (es) | 2004-07-07 | 2016-04-07 | Biocon Limited | Síntesis de compuestos inmunorreguladores unidos por grupos azoicos |
| TWI478712B (zh) | 2008-09-30 | 2015-04-01 | Astellas Pharma Inc | 釋控性醫藥組成物 |
| US9044606B2 (en) | 2010-01-22 | 2015-06-02 | Ethicon Endo-Surgery, Inc. | Methods and devices for activating brown adipose tissue using electrical energy |
| US8476227B2 (en) | 2010-01-22 | 2013-07-02 | Ethicon Endo-Surgery, Inc. | Methods of activating a melanocortin-4 receptor pathway in obese subjects |
| CN102633637A (zh) * | 2012-03-30 | 2012-08-15 | 吉林大学 | 有效缓解和治疗便秘的药用配方 |
| US10080884B2 (en) | 2014-12-29 | 2018-09-25 | Ethicon Llc | Methods and devices for activating brown adipose tissue using electrical energy |
| US10092738B2 (en) | 2014-12-29 | 2018-10-09 | Ethicon Llc | Methods and devices for inhibiting nerves when activating brown adipose tissue |
| US12097189B1 (en) | 2024-02-09 | 2024-09-24 | Astellas Pharma Inc. | Pharmaceutical composition for modified release |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1245148A (en) * | 1968-11-18 | 1971-09-08 | Pfizer Ltd | Propanolamine derivatives |
| GB1301134A (en) * | 1970-07-18 | 1972-12-29 | Pfizer Ltd | SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES |
| DE2965655D1 (en) * | 1978-06-28 | 1983-07-21 | Beecham Group Plc | Secondary amines, their preparation, pharmaceutical compositions containing them and their use |
| US4338333A (en) * | 1979-06-16 | 1982-07-06 | Beecham Group Limited | Ethanamine derivatives their preparation and use in pharmaceutical compositions |
| EP0021636B1 (en) * | 1979-06-16 | 1982-12-01 | Beecham Group Plc | Secondary amines, their preparation and use in pharmaceutical compositions |
| EP0025331B1 (en) * | 1979-09-06 | 1983-03-02 | Beecham Group Plc | Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them |
| EP0028105B1 (en) * | 1979-10-25 | 1983-01-19 | Beecham Group Plc | Secondary amines, their preparation and use in pharmaceutical compositions |
| DE3161165D1 (en) * | 1980-05-08 | 1983-11-17 | Beecham Group Plc | Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions |
| EP0061907B1 (en) * | 1981-03-31 | 1984-08-01 | Beecham Group Plc | Secondary amines, their preparation, pharmaceutical compositions containing them and their use |
| EP0063004A1 (en) * | 1981-04-09 | 1982-10-20 | Beecham Group Plc | Secondary amines, processes for their preparation, and pharmaceutical compositions containing them |
| GB8519154D0 (en) * | 1985-07-30 | 1985-09-04 | Ici Plc | Aromatic ethers |
| IT1204416B (it) * | 1986-06-27 | 1989-03-01 | Midy Spa | Medicamenti a base di analoghi di feniletanolammine per il trattamento di disturbi gastro-intestinali ed uterini |
| GB8714901D0 (en) * | 1986-07-23 | 1987-07-29 | Ici Plc | Amide derivatives |
| GB2212801A (en) * | 1987-11-26 | 1989-08-02 | Resolution Chemicals Limited | Preparation of an alkanolamine derivatives |
| GB8801306D0 (en) * | 1988-01-21 | 1988-02-17 | Ici Plc | Chemical compounds |
| GB8910374D0 (en) * | 1989-05-05 | 1989-06-21 | Ici Plc | Chemical compounds |
| US5236951A (en) * | 1989-06-13 | 1993-08-17 | Sanofi | Pharmaceutical compositions for the treatment of ocular disorders |
-
1991
- 1991-05-28 GB GB919111426A patent/GB9111426D0/en active Pending
-
1992
- 1992-05-07 NZ NZ242643A patent/NZ242643A/en unknown
- 1992-05-08 ZA ZA923356A patent/ZA923356B/xx unknown
- 1992-05-10 IL IL101821A patent/IL101821A0/xx unknown
- 1992-05-11 CA CA002068377A patent/CA2068377A1/en not_active Abandoned
- 1992-05-15 HU HU9201609A patent/HU211401B/hu not_active IP Right Cessation
- 1992-05-18 AP APAP/P/1992/000385A patent/AP301A/en active
- 1992-05-19 KR KR1019920008405A patent/KR920021492A/ko not_active Application Discontinuation
- 1992-05-20 RU SU925011728A patent/RU2073666C1/ru active
- 1992-05-21 AU AU17044/92A patent/AU652826B2/en not_active Ceased
- 1992-05-22 ES ES92304653T patent/ES2076688T3/es not_active Expired - Lifetime
- 1992-05-22 DK DK92304653.6T patent/DK0516349T3/da active
- 1992-05-22 AT AT92304653T patent/ATE128115T1/de not_active IP Right Cessation
- 1992-05-22 EP EP92304653A patent/EP0516349B1/en not_active Expired - Lifetime
- 1992-05-22 DE DE69204906T patent/DE69204906T2/de not_active Expired - Fee Related
- 1992-05-22 GB GB929210919A patent/GB9210919D0/en active Pending
- 1992-05-25 YU YU54592A patent/YU54592A/sh unknown
- 1992-05-25 MY MYPI92000893A patent/MY136249A/en unknown
- 1992-05-26 CS CS921592A patent/CS159292A3/cs unknown
- 1992-05-26 CN CN92103977A patent/CN1031564C/zh not_active Expired - Fee Related
- 1992-05-27 JP JP13484692A patent/JP3232337B2/ja not_active Expired - Fee Related
- 1992-05-27 NO NO92922113A patent/NO922113L/no unknown
- 1992-05-27 SI SI19929200093A patent/SI9200093A/sl unknown
- 1992-05-27 BR BR929202002A patent/BR9202002A/pt not_active Application Discontinuation
- 1992-05-27 FI FI922424A patent/FI922424A/fi not_active Application Discontinuation
- 1992-05-27 OA OA60218A patent/OA10077A/en unknown
- 1992-05-27 PL PL29470492A patent/PL294704A1/xx unknown
- 1992-05-28 BG BG096392A patent/BG96392A/bg unknown
- 1992-05-28 RO RO92-200738A patent/RO111569B1/ro unknown
- 1992-05-28 US US07/889,196 patent/US5393779A/en not_active Expired - Lifetime
- 1992-06-02 TW TW081104319A patent/TW198709B/zh active
- 1992-07-01 IE IE921447A patent/IE69043B1/en not_active IP Right Cessation
-
1994
- 1994-11-18 US US08/344,708 patent/US5434184A/en not_active Expired - Lifetime
-
1995
- 1995-03-06 HU HU95P/P00087P patent/HU210799A9/hu unknown
- 1995-05-10 US US08/437,988 patent/US5480910A/en not_active Expired - Lifetime
- 1995-09-21 GR GR950402415T patent/GR3017462T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0516349T3 (da) | 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister | |
| FI933167A (fi) | N-alkylkinuklidiniumsalter som substans-p antagonister | |
| MX9205145A (es) | Nuevos derivados heterociclicos. | |
| FI921182A (fi) | Velangummi som snabbt hydratiseras | |
| DE69208877D1 (de) | Chinuclidinderivate | |
| NO922182D0 (no) | Krystallinske oksatiolan-derivater | |
| DK0533268T3 (da) | Benzanilidderivater som 5HT-1D antagonister | |
| NO940974D0 (no) | Benzanilid-derivater som 5-HT1D antagonister | |
| FI931111A (fi) | Staongtvaolskompositioner som innehaoller sackaros | |
| FI944805A (fi) | Indolijohdannaisia 5-HT1-kaltaisina agonisteina | |
| FI940574A (fi) | Bentseenisulfonamidijohdannaiset herbisideinä | |
| FI922973A (fi) | Tokoferolblandning foer anvaendning som antioxidant foer krusmyntolja i tuggummi | |
| FI925763A0 (fi) | Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat | |
| FI940469A0 (fi) | Kinoliinijohdannaisia immunostimulantteina | |
| FI925284A (fi) | Inkapslade partiklar anvaendbara som kontrastmedel i kompositioner och metoder, som anvaends vid ultraljud- och roentgenavbildning | |
| TR26336A (tr) | SüBSTITüE EDILMIS PIRAZOLIN TüREVLERI | |
| FI931868A0 (fi) | Finishingblandning foer yta | |
| FI932454A0 (fi) | Ansiktsemulsionskompositioner som laemnas pao huden | |
| MX9200169A (es) | Derivados de sulfonamida | |
| FI925469A (fi) | Tiazolylsubstituerade kinolylymetoxifenylaettiksyraderivat | |
| FI921666A (fi) | Indolin- och dihydrokinolinfoereningar som oeppnare av kaliumkanal | |
| FI923555A (fi) | Foerfarande foer framstaellning av mattor som bestaor av minst tvao med varandra bundna skikt | |
| FI930342A (fi) | Pentapeptider som reglerar immun- och nervsystem | |
| FI924440A (fi) | Heterocykliska foereningar som aldosreduktasinhibitorer | |
| KR930702353A (ko) | 2- 카르바페넴 유도체 |